Patients Mainly Prefer AI as Second Reader for Screening Mammogram
WEDNESDAY, April 23, 2025 -- Use of artificial intelligence (AI) as a second reader in screening mammography is accepted by patients, according to a study published online April 18 in Radiology: Imaging Cancer.
B. Bersu Ozcan, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues conducted a prospective study involving 518 patients undergoing mammography screening between February and August 2023 who were offered a 29-question survey. Independent factors associated with participants' acceptance of AI use were examined.
The researchers found that 76.5 percent of participants reported no or minimal knowledge of AI. Overall, 4.44 percent accepted stand-alone AI interpretation, while 71.0 percent preferred AI to be used as a second reader. Most participants (88.9 percent) requested radiologist review after an AI-reported abnormality, compared with 51.3 percent who requested radiologist recall review by AI. A higher number of participants would undergo diagnostic examination for radiologist recalls versus AI recalls in cases of discrepancy, although the difference was not significant (94.2 versus 92.6 percent). Greater AI acceptance was seen in association with higher education (odds ratio, 2.05). Concern for bias was seen in association with race and was higher in Hispanic and non-Hispanic Black versus non-Hispanic White participants (odds ratios, 3.32 and 4.31, respectively).
"Our results indicate a cautious optimism among participants about the integration of AI in mammogram interpretation," the authors write.
One author disclosed ties to the publishing and medical device industries and holds a related patent.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Lung Cancer Screening Beneficial to Age 80 for Candidates Fit for Surgery
FRIDAY, Sept. 12, 2025 -- People aged 75 to 80 years at last screen who are diagnosed with screen-detected lung cancer (LC) have lower overall survival, but those undergoing...
Sex Differences Seen in Characteristics, Course of Schizophrenia, Bipolar Disorder
FRIDAY, Sept. 12, 2025 -- Significant sex differences are seen in the characteristics and course of schizophrenia (SZ) and bipolar disorder (BD), according to a study published...
Potentially Inappropriate Medications Linked to Frailty at Cancer Diagnosis
FRIDAY, Sept. 12, 2025 -- For patients with newly diagnosed cancer, an increasing number of potentially inappropriate medications (PIMs), as identified by the Geriatric Oncology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.